Search research articles
Contact Us
Filters
Showing results (571-580 of 591) with videos related to
Page
of 60
Sort By:
Critical Care Medicine
|
January 13, 2005
Effect of cerebral perfusion pressure augmentation on regional oxygenation and metabolism after head injury
Andrew J Johnston, Luzius A Steiner, Jonathan P Coles, et al.
Journal of Neurosurgery
|
October 7, 1998
A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury
L F Marshall, A I Maas, S B Marshall, et al.
Neurorehabilitation and Neural Repair
|
April 30, 2015
Dynamic Changes in White Matter Abnormalities Correlate With Late Improvement and Deterioration Following TBI: A Diffusion Tensor Imaging Study
Virginia F J Newcombe, Marta M Correia, Christian Ledig, et al.
Frontiers in Neurology
|
July 29, 2022
Clinical Outcomes After Ventriculo-Peritoneal Shunting in Patients With Classic vs. Complex NPH
Eng Tah Goh, Christine Lock, Audrey Jia Luan Tan, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
January 30, 2004
Incidence and mechanisms of cerebral ischemia in early clinical head injury
Jonathan P Coles, Tim D Fryer, Piotr Smielewski, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2019
Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management
Helen J Gogas, Keith T Flaherty, Reinhard Dummer, et al.
JAMA Neurology
|
November 13, 2013
Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury
Young T Hong, Tonny Veenith, Deborah Dewar, et al.
The Lancet. Oncology
|
September 17, 2018
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial
Reinhard Dummer, Paolo A Ascierto, Helen J Gogas, et al.
The Lancet. Oncology
|
March 26, 2018
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
Reinhard Dummer, Paolo A Ascierto, Helen J Gogas, et al.
Brain : a Journal of Neurology
|
July 9, 2021
Metabolic derangements are associated with impaired glucose delivery following traumatic brain injury
Jeroen Hermanides, Young T Hong, Monica Trivedi, et al.
Page
of 60
Search research articles
Search
Showing results (571-580 of 591) with videos related to
Sort By:
Page
of 60
Critical Care Medicine
|
January 13, 2005
Effect of cerebral perfusion pressure augmentation on regional oxygenation and metabolism after head injury
Andrew J Johnston, Luzius A Steiner, Jonathan P Coles, et al.
Journal of Neurosurgery
|
October 7, 1998
A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury
L F Marshall, A I Maas, S B Marshall, et al.
Neurorehabilitation and Neural Repair
|
April 30, 2015
Dynamic Changes in White Matter Abnormalities Correlate With Late Improvement and Deterioration Following TBI: A Diffusion Tensor Imaging Study
Virginia F J Newcombe, Marta M Correia, Christian Ledig, et al.
Frontiers in Neurology
|
July 29, 2022
Clinical Outcomes After Ventriculo-Peritoneal Shunting in Patients With Classic vs. Complex NPH
Eng Tah Goh, Christine Lock, Audrey Jia Luan Tan, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
January 30, 2004
Incidence and mechanisms of cerebral ischemia in early clinical head injury
Jonathan P Coles, Tim D Fryer, Piotr Smielewski, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 23, 2019
Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management
Helen J Gogas, Keith T Flaherty, Reinhard Dummer, et al.
JAMA Neurology
|
November 13, 2013
Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury
Young T Hong, Tonny Veenith, Deborah Dewar, et al.
The Lancet. Oncology
|
September 17, 2018
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial
Reinhard Dummer, Paolo A Ascierto, Helen J Gogas, et al.
The Lancet. Oncology
|
March 26, 2018
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
Reinhard Dummer, Paolo A Ascierto, Helen J Gogas, et al.
Brain : a Journal of Neurology
|
July 9, 2021
Metabolic derangements are associated with impaired glucose delivery following traumatic brain injury
Jeroen Hermanides, Young T Hong, Monica Trivedi, et al.
Page
of 60